SEMA3C expression is correlated with expression of steroidogenic enzymes CYP11A1 and SRD5A2 as well as the AR target gene, FKBP5, in prostate adenocarcinoma patients according to TCGA PanCancer dataset available on cBioPortal. Here, AR is linked to prostate adenocarcinoma.